RBM-007 Injectable Solution

DRUG3 trials

Sponsors

Ribomic USA Inc, Maturi, Raj K., M.D., P.C.

Conditions

Age Related Macular DegenerationAge-related Macular DegenerationExudative Age-related Macular Degeneration

Phase 1

RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

CompletedNCT03633084

Ribomic USA IncAge-related Macular Degeneration

Start: 2018-08-29End: 2019-06-26Updated: 2021-01-05

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration

CompletedNCT04895293

Maturi, Raj K., M.D., P.C.Age Related Macular Degeneration

Start: 2021-06-15End: 2022-03-04Updated: 2023-04-12

Phase 2

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

CompletedNCT04200248

Ribomic USA IncExudative Age-related Macular Degeneration

Start: 2019-12-02End: 2021-12-22Updated: 2023-06-08